Some of the following documents are PDF files.
They may be viewed and
printed using the free Adobe Acrobat Reader (click on icon above).
Peer-Reviewed Journal
Articles, 2005
Knapp,
F. F., Jr. “The Continuing Important Role of
High Flux Reactors for Production of Therapeutic Medical
Radioisotopes,” Invited Lecture, For, International
Symposium on Trends in Radiopharmaceuticals, IAEA,
Vienna, Austria, November 14-18, 2005.
Knapp,
F. F., Jr. “Therapeutic Applications of Rhenium-188
in Nuclear Medicine and Oncology – Current Status
and Future Perspectives,” Invited Lecture,
For, International Conference on Radiopharmaceutical
Therapy, World Radiopharmaceutical Therapy Council,
WFNMB, Limassol, Cyprus, October 11-14, 2005.
Knapp,
F. F., Jr., Mirzadeh, S., Stabin, M. and Brill, A.
B. ”Therapy with High LET Radioisotopes – Can
Sufficient Levels of Attractive Auger and Alpha Emitters
be Produced to Make Their Use Practical ?,” Invited
Lecture, For, International Conference on Radiopharmaceutical
Therapy, World Radiopharmaceutical Therapy Council,
WFNMB, Limassol, Cyprus, October 11-14, 2005.
Knapp,
F. F., Jr. “Therapeutic Applications of Rhenium-188
in Nuclear Medicine and Oncology – Current Status
and Future Perspectives,” For, Symposium
on Radioisotope Therapy, Havana, Cuba, June 24-28,
2005.
Knapp,
F. F., Jr., Mirzadeh, S., Beets, A. L., Du., M., Klein,
J. A. and Garland, M. “Direct Production of Lutetium-177
from Enriched Lu-176 in a High Flux Reactor – The
Only Practical Route to Provide High Specific Activity/Multi-Curie
Levels of Lu-177 Required fro Routine Clinical Use,“ For,
5th International Conference on Isotopes (5ICI),
Brussels, Belgium, April 24-29, 2005.
Knapp,
F. F., Jr. “The Important Role of Research Reactors
for Production of Medical Radioisotopes,” Department
of Nuclear Medicine, Seoul National University Hospital,
Seoul, Korea, April 15, 2005.
Boll,
R. A., Malkemus, D. and Mirzadeh, S. “Production
of Actinium-225 for Alpha Particle-Mediated Radioimmunotherapy,” Appl.
Radiat. Isot., 62, 667-679 (2005).
Kennel, S. J., Lankford, P., Garland, M., Sundberg, J. P. and Mirzadeh, S. “Biodistribution of Ra-225 Citrate in Mice: Retention of Daughter Radioisotopes in Bone,“ Nucl. Med. Biol., 32, 859-867 (2005).
Knapp,
F. F., Jr., Mirzadeh, S., Beets, A. L. and Du, M. ”Production
of Therapeutic Radioisotopes in the ORNL High Flux Isotope
Reactor for Applications in Nuclear Medicine, Oncology
and Interventional Cardiology,“ J. Radioanalyt.
Nuc. Chem.,
263 (2), 503-509 (2005).
Meeting Presentations and Published Abstracts
Knapp, F. F., Jr., Mirzaeh, S., and Garland, M. “The Continuing Important Role of High Flux Reactors for Production of Therapeutic Medical Radioisotopes,” Invited Lecture, For, TECDOC, International Symposium on Trends in Radiopharmaceuticals, IAEA, Vienna, Austria, in press.
Monroy-Guzman, F., Badillo Almaraz, V. E., Flores de la Torre, J. A., Cosgrove, J. M. and Knapp, F. F., Jr. “Hydroxyapatite-Based Mo-99/Tc-99m and W-188/re-188 Generator Systems,” For, TECDOC, International Symposium on Trends in Radiopharmaceuticals, IAEA, Vienna, Austria, in press.
Knapp,
F. F., Jr. “The Production and Use of Therapeutic
Radionuclides for Nuclear Medicine and Oncology Applications,” Invited
Lecture, Hannoro 2005 Conference – The 10th
Anniversary, Korea Atomic Energy Research Institute
(KAERI),
April 11-13, 2005.
Knapp, F.
F., Jr., Mirzadeh, S., Beets, A. L., Du., M., Klein,
J. A. and Garland, M. “Direct Production
of Lutetium-177 from Enriched Lu-176 in a High Flux Reactor – The
Only Practical Route to Provide High Specific Activity/Multi-Curie
Levels of Lu-177 Required fro Routine Clinical Use,“ For,
5th International Conference on Isotopes (5ICI), Brussels,
Belgium, April 14-19, 2005 (submitted).
 Back to Publications page
|
